Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease episode artwork

EPISODE · Feb 9, 2021 · 1H 8M

Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

from The Long Run with Luke Timmerman · host Timmerman Report

Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.

Episode metadata supplied by the publisher feed · Published Feb 9, 2021

Embed this episode

NOW PLAYING

Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

0:00 1:08:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 8 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on February 9, 2021.

Can I download this The Long Run with Luke Timmerman episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!